This Article Full Text (PDF) All Versions of this Article: 0269216308098803v1 22/8/965    most recent References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Soto-Cárdenas, M. Articles by Giron-Gonzalez, J. Search for Related Content PubMed PubMed Citation Articles by Soto-Cárdenas, M. Articles by Giron-Gonzalez, J. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Blood Thinners Palliative Care Social Bookmarking                         What's this?

Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice

Palliative Care Unit, Internal Medicine Department, ‘Puerta del Mar’ University Hospital, Cádiz

G Pelayo-García

Palliative Care Unit, Internal Medicine Department, ‘Puerta del Mar’ University Hospital, Cádiz

A Rodríguez-Camacho

Palliative Care Unit, Internal Medicine Department, ‘Puerta del Mar’ University Hospital, Cádiz

E Segura-Fernández

Palliative Care Unit, Internal Medicine Department, ‘Puerta del Mar’ University Hospital, Cádiz

A Mogollo-Galván

Palliative Care Unit, Internal Medicine Department, ‘Puerta del Mar’ University Hospital, Cádiz

JA Giron-Gonzalez

Palliative Care Unit, Internal Medicine Department, ‘Puerta del Mar’ University Hospital, Cádiz

We analyzed the principal risk factors of venous thromboembolism (VTE) (immobilization, recent surgery and previous VTE), prophylaxis with low-molecular weight heparin (LMWH) and complications (i.e. severe bleeding, recurrence and death). Patients with advanced cancer under palliative care (PC) and with VTE, were reviewed during the three years before the study. 71 Patients were diagnosed with VTE. 88.7% were outpatients. The risk factors present were: immobilizations in 28 patients (39.4%), recent surgery in 5 (7%) and previous VTE in 23 (32.5%). Prophylaxis was used in 4 (14.3%) patients with immobilization, no patient with recent surgery, and 10 (43.4%) patients with previous VTE. After diagnosis, all patients received treatment with LMWH in therapeutic dosage. The complications observed were: 6 recurrences (8.5%), 11 VTE-related deaths (15.5%), and bleeding events occured in 8 cases (11.3%), 4 (5.6%) of whom suffered severe bleeding; of these patients, 3 (4.2%) died as a result of the bleeding events. In PC patients with advanced cancer, VTE is a serious complication that conditions control of symptoms. The presence of other risk factors, immobilization and previous VTE, is common and LMWH prophylaxis is limited in clinical practice. The risks vs benefits of anticoagulation need to be counterbalanced.

Key Words: venous thromboembolism • advanced cancer • palliative care

This version was published on December 1, 2008

Palliative Medicine, Vol. 22, No. 8, 965-968 (2008)
DOI: 10.1177/0269216308098803


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?